Press releases

December 23, 2015

Adjusted additional order from Bard

In August 2015, Bactiguard received a one off order from C.R. Bard (Bard), intended to increase their safety stock, which generated additional sales of approximately 28 MSEK in the third quarter. Bard has subsequently revised their need of safety stock. This adjustment will have a negative impact on Bactiguard’s revenues of approximately 8 MSEK.

December 18, 2015

Ninth year for Bactiguard at Arab Health

For the ninth year in a row Bactiguard is exhibiting at Arab Health, which is one of the world's largest conferences for the health care sector. The interest in preventive and anti-infective solutions for healthcare associated infections are growing explosively along with the global threat of multiresistant bacteria and antibiotic resistance.

December 10, 2015

Changes to the Nomination Committee appointed for the Annual General Meeting 2016

Attorney Jan Lombach will replace Christian Kinch and has also been appointed chairman of the Nomination Committee.

December 09, 2015

Large clinical study starting in India

The planned multi-center clinical study in India has been initiated and the first patients recruited at two reputable hospitals. The purpose of the study is to further validate the efficiency and patient safety of Bactiguard’s Foley catheters in the prevention of catheter-related urinary tract infections.

December 09, 2015

Major order from India

Bactiguard has received a major order from India of some 50 000 Foleys for infection prevention. At the same time, the planned clinical study has been initiated.

November 23, 2015

Growing interest in infection prevention in the Middle East

Bactiguard has received an order from the Middle East, comprising 2 000 central venous catheters (BIP CVC) and 20 000 Foleys (BIP Foley). The delivery will take place before the end of the year.

November 18, 2015

Nomination Committee appointed for the Annual General Meeting 2016

The Annual General Meeting in Bactiguard Holding AB (publ) will be held on Thursday 19 May, 2016 in Botkyrka.

November 12, 2015

Breaking new ground and strengthening the financial position

Third Quarter (July-September 2015) Revenues amounted to SEK 61.4 (28.1) million. The increase (118 %) compared to the corresponding quarter 2014 is mainly attributable to the additional order from C.R. Bard. EBITDA amounted to SEK 33.9 (2.2) milli...
November 11, 2015

Bactiguard enters new therapeutic area through license agreement

Bactiguard and Vigilenz Medical Devices (Vigilenz), a Malaysian supplier of medical and surgical products, have entered into a license agreement for Bactiguard coated orthopaedic implants, covering the Asean region.

November 10, 2015

Bactiguard secures financing

Bactiguard has entered a credit facility agreement of 130 million SEK in total. Combined with the company’s cash position, the credit facility secures the refinancing of Bactiguard’s bond loan, which matures in December 2016.